AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 339 filers reported holding AVANOS MED INC in Q1 2019. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $513,756 | -22.5% | 20,100 | -9.9% | 0.00% | 0.0% |
Q1 2023 | $663,202 | -92.2% | 22,300 | -91.2% | 0.00% | -93.8% |
Q1 2022 | $8,493,000 | +650.9% | 253,525 | +677.7% | 0.02% | +700.0% |
Q4 2021 | $1,131,000 | +15.3% | 32,601 | +3.7% | 0.00% | -50.0% |
Q3 2021 | $981,000 | -54.0% | 31,441 | -35.6% | 0.00% | -60.0% |
Q1 2021 | $2,134,000 | +12.7% | 48,785 | -14.4% | 0.01% | -16.7% |
Q3 2020 | $1,894,000 | -52.8% | 57,024 | -58.2% | 0.01% | -57.1% |
Q2 2020 | $4,010,000 | +109.2% | 136,472 | +91.7% | 0.03% | +47.4% |
Q1 2020 | $1,917,000 | +53.7% | 71,194 | +113.9% | 0.02% | +90.0% |
Q3 2019 | $1,247,000 | -83.3% | 33,280 | -80.5% | 0.01% | -83.6% |
Q2 2019 | $7,460,000 | +98.1% | 171,064 | +94.0% | 0.06% | +238.9% |
Q1 2019 | $3,766,000 | -46.0% | 88,190 | -43.4% | 0.02% | -74.6% |
Q4 2018 | $6,979,000 | -31.2% | 155,837 | +5.2% | 0.07% | +65.1% |
Q3 2018 | $10,144,000 | – | 148,102 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |